UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Osimertinib-induced lymphocytopenia and pneumocystis jirovecii pneumonia

Pulmonology, 2022-09, Vol.28 (5), p.403-405

2022

Volltextzugriff (PDF)

CHARACTERISTICS OF CHRONIC PROGRESSIVE AIRFLOW LIMITATION OF ASTHMA DEPICTED BY MEANS OF 30 YEARS OF SPIROMETRY DATA FROM ANNUAL HEALTH CHECKUP RECORDS

Chest, 2020-06, Vol.157 (6), p.A299-A299

2020

Volltextzugriff (PDF)

P1.04-34 Efficacy and Safety of First-Line Pembrolizumab Monotherapy in Elderly Patients (Aged ≥ 75 years) with Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S453-S453

2019

Volltextzugriff (PDF)

Luminal Findings of a Bronchogenic Cyst

American journal of respiratory and critical care medicine, 2021-09, Vol.204 (6), p.e59-e60

2021

Volltextzugriff (PDF)

Wheezing and Weightlifting

Internal Medicine, 2022/03/15, Vol.61(6), pp.931-932

2022

Volltextzugriff (PDF)

Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission Tomography

Internal Medicine, 2019/12/01, Vol.58(23), pp.3487-3488

2019

Volltextzugriff (PDF)

Atezolizumab-Induced Immune-Related Pneumonia on Rounded Atelectasis

The clinical respiratory journal, 2024-09, Vol.18 (9), p.e70008-n/a

2024

Volltextzugriff (PDF)

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2020-04, Vol.85 (4), p.761-771

2020

Volltextzugriff (PDF)

Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission Tomography

Internal Medicine, 2020, pp.3215-19

2020

Volltextzugriff (PDF)

Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer

Internal Medicine, 2024, pp.3649-24

2024

Volltextzugriff (PDF)

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

Journal of cancer research and clinical oncology, 2020-02, Vol.146 (2), p.457-466

2020

Volltextzugriff (PDF)

Wheezing and Weightlifting

Internal Medicine, 2021, pp.8179-21

2021

Volltextzugriff (PDF)

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.73-83

2023

Volltextzugriff (PDF)

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

Frontiers in oncology, 2023-01, Vol.12, p.1080729-1080729

2023

Volltextzugriff (PDF)

Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy

Thoracic cancer, 2022-07, Vol.13 (14), p.2031-2040

2022

Volltextzugriff (PDF)

Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity

Respiratory investigation, 2021-03, Vol.59 (2), p.247-251

2021

Volltextzugriff (PDF)

Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed

Thoracic cancer, 2023-09, Vol.14 (25), p.2567-2578

2023

Volltextzugriff (PDF)

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

Investigational new drugs, 2022-10, Vol.40 (5), p.1066-1079

2022

Volltextzugriff (PDF)

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

Thoracic cancer, 2022-10, Vol.13 (19), p.2776-2785

2022

Volltextzugriff (PDF)

Mass spectrometric study of photo dissociation of organic molecules by vacuum-ultraviolet irradiation for development of analysis technique

Applied surface science, 2009-09, Vol.255 (24), p.9861-9863

2009

Volltextzugriff (PDF)

Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis

Thoracic cancer, 2020-10, Vol.11 (10), p.2867-2876

2020

Volltextzugriff (PDF)

Study of Refractive Index Change in Ge-Doped Fibers with Vacuum Ultraviolet Light Irradiation

Japanese Journal of Applied Physics, 2008-09, Vol.47 (9R), p.7266

2008

Volltextzugriff (PDF)

Development of Mass Production Technique of Optical Fiber Bragg Grating by All Solid-State Near-UV Laser

Rēzā kenkyū, 2010-10, Vol.38 (10), p.774-778

2010

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Osimertinib-induced lymphocytopenia and pneumocystis jirovecii pneumonia

CHARACTERISTICS OF CHRONIC PROGRESSIVE AIRFLOW LIMITATION OF ASTHMA DEPICTED BY MEANS OF 30 YEARS OF SPIROMETRY DATA FROM ANNUAL HEALTH CHECKUP RECORDS

P1.04-34 Efficacy and Safety of First-Line Pembrolizumab Monotherapy in Elderly Patients (Aged ≥ 75 years) with Non-Small Cell Lung Cancer

Luminal Findings of a Bronchogenic Cyst

Wheezing and Weightlifting

Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission Tomography

Atezolizumab-Induced Immune-Related Pneumonia on Rounded Atelectasis

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer

Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission Tomography

Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

Wheezing and Weightlifting

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy

Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity

Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed

Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

Mass spectrometric study of photo dissociation of organic molecules by vacuum-ultraviolet irradiation for development of analysis technique

Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis

Study of Refractive Index Change in Ge-Doped Fibers with Vacuum Ultraviolet Light Irradiation

Development of Mass Production Technique of Optical Fiber Bragg Grating by All Solid-State Near-UV Laser

Suchergebnisse filtern